The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Kalkers NF, Barkhof F, Bergers E, van Schijndel R, Polman CH Mult Scler. 2002 Dec; 8(6):532-3. PMID: 12474997. Abstract CommentRecommendBookmarkWatch